PapersPMID:41236933
Basil (Ocimum basilicum) to Alleviate Anxiety in Patients With Major Depressive Disorder: A Randomized Placebo-Controlled Clinical Trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 4 weeks
- Dose studied, every finding
- 1100 mg hydroalcoholic extract in 5 mL syrup, once nightly before sleep
- Population, every finding
- Adults aged 18-65 with major depressive disorder and concurrent anxiety (HAM-A 18 or above), all taking sertraline 50-100 mg/day in both arms; single-blind, 4 weeks
What moved
How to read these marks →“The reduction in BDI scores was significantly greater in the basil group compared to the placebo group (p < 0.001).”
“The reduction in HAM‐A scores was significantly greater in the basil group compared to the placebo group (p < 0.001).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults aged 18-65 years with major depressive disorder and concurrent anxiety (HAM-A at least 18), treated with sertraline; basil hydroalcoholic leaf extract syrup (Ocimum basilicum) vs placebo syrup
- Participants
- 60
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 8